Sean F Moran's Net Worth
Sean F Moran's net worth is estimated to be at least $2,096,743.87 as of 12/22/2024. CoreStreet's estimation of Sean F Moran's net worth is based on their sale of stock and current holding of stock.
Sean F Moran is CFO at Corbus Pharmaceuticals Holding. They have executed at least 51 trades of stock as per SEC Form 4 filings. Their most recent trade was for 1,958 units of CRBP stock on 06/18/2024. Their biggest sale was on 06/14/2024 when they sold 9,355 units of Corbus Pharmaceuticals Holding stock for $466,533.85. They typically trade 5 times per year.
Total value of insider buys:
- $1,270,821.70
Total value of insider sells:
- $825,922.17
Most recent insider trade:
- June 18, 2024
Sean F Moran's Insider Trading History
| Corbus Pharmaceuticals Holding | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
June 18, 2024 | CFO | 1,958 | $42.12 | Sell | $82,470.96 |
June 14, 2024 | CFO | 9,355 | $49.87 | Sell | $466,533.85 |
Aug. 10, 2022 | CFO | 20,000 | $0.26 | Buy | $5,200.00 |
May 16, 2022 | CFO | 12,000 | $0.30 | Buy | $3,600.00 |
March 10, 2022 | CFO | 15,000 | $0.37 | Buy | $5,550.00 |
Dec. 21, 2020 | CFO | 87,500 | $1.75 | Sell | $153,125.00 |
Dec. 18, 2020 | CFO | 53,610 | $1.40 | Sell | $75,054.00 |
Dec. 16, 2020 | CFO | 36,923 | $1.32 | Sell | $48,738.36 |
May 14, 2019 | CFO | 100 | $7.12 | Buy | $712.00 |
March 14, 2019 | CFO | 1,500 | $6.67 | Buy | $10,005.00 |
May 15, 2018 | CFO | 4,000 | $5.77 | Buy | $23,080.00 |
March 14, 2018 | CFO | 3,100 | $6.60 | Buy | $20,460.00 |
Nov. 10, 2017 | CFO | 1,500 | $7.04 | Buy | $10,560.00 |
Aug. 11, 2017 | CFO | 2,500 | $5.91 | Buy | $14,775.00 |
May 11, 2017 | CFO | 3,300 | $6.14 | Buy | $20,262.00 |
March 13, 2017 | CFO | 2,000 | $9.60 | Buy | $19,200.00 |
Dec. 2, 2016 | CFO | 1,500 | $7.20 | Buy | $10,800.00 |
Sept. 8, 2016 | CFO | 30,800 | $5.12 | Buy | $157,696.00 |
Aug. 26, 2016 | CFO | 17,900 | $3.92 | Buy | $70,168.00 |
Aug. 18, 2016 | CFO | 148,960 | $3.32 | Buy | $494,547.20 |
May 19, 2016 | CFO | 27,250 | $2.37 | Buy | $64,582.50 |
May 18, 2016 | CFO | 30,000 | $2.39 | Buy | $71,700.00 |
Dec. 11, 2015 | CFO | 1,000 | $1.56 | Buy | $1,560.00 |
Dec. 10, 2015 | CFO | 1,000 | $1.61 | Buy | $1,610.00 |
Dec. 9, 2015 | CFO | 1,000 | $1.67 | Buy | $1,670.00 |
Dec. 8, 2015 | CFO | 1,000 | $1.68 | Buy | $1,680.00 |
Dec. 7, 2015 | CFO | 1,000 | $1.69 | Buy | $1,690.00 |
Dec. 4, 2015 | CFO | 1,000 | $1.72 | Buy | $1,720.00 |
Dec. 2, 2015 | CFO | 1,000 | $1.79 | Buy | $1,790.00 |
Nov. 24, 2015 | CFO | 1,500 | $1.78 | Buy | $2,670.00 |
Nov. 20, 2015 | CFO | 1,500 | $1.70 | Buy | $2,550.00 |
Nov. 18, 2015 | CFO | 1,500 | $1.71 | Buy | $2,565.00 |
Nov. 17, 2015 | CFO | 1,500 | $1.72 | Buy | $2,580.00 |
Nov. 16, 2015 | CFO | 2,000 | $1.69 | Buy | $3,380.00 |
Sept. 16, 2015 | CFO | 5,000 | $2.12 | Buy | $10,600.00 |
Sept. 15, 2015 | CFO | 5,000 | $2.14 | Buy | $10,700.00 |
Sept. 14, 2015 | CFO | 5,000 | $1.96 | Buy | $9,800.00 |
Sept. 11, 2015 | CFO | 5,000 | $1.85 | Buy | $9,250.00 |
Aug. 21, 2015 | CFO | 1,400 | $2.06 | Buy | $2,884.00 |
Aug. 18, 2015 | CFO | 1,000 | $1.92 | Buy | $1,920.00 |
June 9, 2015 | CFO | 6,500 | $3.00 | Buy | $19,500.00 |
Dec. 18, 2014 | CFO | 18,800 | $3.36 | Buy | $63,168.00 |
Dec. 17, 2014 | CFO | 2,850 | $3.46 | Buy | $9,861.00 |
Dec. 11, 2014 | CFO | 1,000 | $3.98 | Buy | $3,980.00 |
Dec. 9, 2014 | CFO | 1,700 | $3.98 | Buy | $6,766.00 |
Dec. 4, 2014 | CFO | 2,000 | $3.20 | Buy | $6,400.00 |
Dec. 2, 2014 | CFO | 1,000 | $3.03 | Buy | $3,030.00 |
Nov. 26, 2014 | CFO | 1,000 | $3.05 | Buy | $3,050.00 |
Nov. 25, 2014 | CFO | 3,000 | $3.05 | Buy | $9,150.00 |
| InVivo Therapeutics Holdings Corp | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Sept. 3, 2013 | CFO | 20,000 | $1.02 | Buy | $20,400.00 |
Aug. 30, 2013 | CFO | 40,000 | $1.30 | Buy | $52,000.00 |